Table 2.
Induce medium OR supplement | Species | Efficiency | Differentiation manner | Ref. |
---|---|---|---|---|
IMDM | Mice | ~55% beating EBs | EB formation | [16] |
α-MEM and coculture | Mice | Unclear | Direct differentiation | [74] |
DMEM/F12 | Human | ~10% beating or bellow | EB formation | [17] |
α-MEM | Human | Unclear | EB formation | [79] |
DMEM | Human | Unclear | EB formation | [80] |
5-AZ or BMP-4 or DMSO | Human | 23.7% of cells by 5-AZ | EB formation | [81] |
IMDM | Murine | Unclear | EB formation | [82] |
Ascorbic acid | Mice; human | Unclear | Through Isl1(+) progenitors | [83] |
IMDM | Mice | Unclear | EB formation | [84] |
DMEM and coculture on END2 cells | Human | ~12.8±3.5% beating EBs | Cell clumps | [85] |
TSA | Mice | Unclear | Direct differentiation | [77] |
FGF-10 | Mice | Unclear | EB formation | [86] |
RPMI+B27 (+Activin A/BMP4/bFGF) | Human | 30-70% Beating EBs | Monolayer culture | [75] |
Cyclosporin-A | Mice | Unclear | Through Flk1+ cells | [87] |
DMEM | Mice | Unclear | EB formation | [88] |
Insulin+ BMP4+FGF2 | Human | >90% | EB formation | [76] |
Sulfonyl-hydrazone-1 | Mice | Unclear | EB formation | [89] |
DMEM, EBM-2 | Mice | ~44.8% | EB formation | [90] |
Stem Pro-34 medium + ascorbic acid + PenStrep + monothioglycerol + Activin A + BMP4 + bFGF | Human | More than 50% | Direct differentiation as a monolayer | [78] |